APA (7th ed.) Citation

RG, F., A, Z., GW, R., I, A., AS, A., M, B., . . . LS, M. (2026). Allogeneic Hematopoietic Cell Transplant Following Standard of Care Brexucabtagene Autoleucel (Brexu-cel) in Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): Results from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA). Transplantation and cellular therapy. https://doi.org/10.1016/j.jtct.2026.06.039

Chicago Style (17th ed.) Citation

RG, Faramand, et al. "Allogeneic Hematopoietic Cell Transplant Following Standard of Care Brexucabtagene Autoleucel (Brexu-cel) in Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): Results from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA)." Transplantation and Cellular Therapy 2026. https://doi.org/10.1016/j.jtct.2026.06.039.

MLA (9th ed.) Citation

RG, Faramand, et al. "Allogeneic Hematopoietic Cell Transplant Following Standard of Care Brexucabtagene Autoleucel (Brexu-cel) in Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): Results from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA)." Transplantation and Cellular Therapy, 2026, https://doi.org/10.1016/j.jtct.2026.06.039.